BioCentury
ARTICLE | Clinical News

Cel-Sci preclinical data

December 6, 2010 8:00 AM UTC

In a mouse model of collagen-induced arthritis, a single dose of CEL-2000 formulated with DepoVax delivery technology from ImmunoVaccine Inc. (TSX-V:IMV, Halifax, Nova Scotia) slowed the progression ...